Christodoulos Papadopoulos: Oral Anticoagulation Monotherapy in Chronic Coronary Syndrome
Christodoulos Papadopoulos, Associate Professor in Cardiology at Aristotle University of Thessaloniki, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Journal of Preventive Cardiology, adding:
“Our recent meta-analysis on antithrombotic strategy in CCS patients needing oral anticoagulation, nicely executed mainly by Anastasios Tsarouchas.
Major conclusion: OAC monotherapy reduces bleeding while not increasing ischemic events.
Mine interpretation: Try to limit long lasting combination therapy (more than 3 months) especially in frail patients.”
Title: Oral anticoagulant monotherapy vs. combination therapy in patients with chronic coronary syndrome: a systematic review and meta-analysis of randomized trials
Authors: Anastasios Tsarouchas, David Mutschlechner, Maximilian Tscharre, Christodoulos E Papadopoulos, Thomas Gremmel
Stay updated on all scientific advances Hemostasis Today.
-
Aug 25, 2026, 13:30Danny Hsu: AIMS 2026 to Spotlight Differential Diagnosis of Thrombotic Microangiopathy
-
Aug 25, 2026, 12:26Rahaf M. Altahan: Diagnosis and Management of Factor XIII Deficiency
-
Aug 25, 2026, 12:17Ifeanyichukwu Ifechidere: Coagulation Knowledge in Cardiology
-
Aug 25, 2026, 12:14Annie Bauzon: Platelets – The Tiny Cells That Stop You From Bleeding
-
Aug 25, 2026, 12:10Marloes de Kovel: FVIII Exposure With Severe Haemophilia A on Emicizumab Prophylaxis
-
Aug 25, 2026, 11:59What Happens When the Next Generation of Hematologists Looks Elsewhere? – Global Hemophilia Report
-
Aug 25, 2026, 11:54Kimberly Jacobson: MSL Opportunity in Rare Blood and Bleeding Disorders
-
Aug 25, 2026, 11:48GPAS 2026 Advancing Access and Equity in Bleeding Disorders – WFH
-
Aug 25, 2026, 11:41Gregory Lip: Don’t Miss – €1,000 Mechanical Thrombectomy Grant